| KOTAK MNC FUND
An open-ended equity scheme following Multi-national Companies (MNC) theme
| KOTAK MNC FUND
An open-ended equity scheme following Multi-national Companies (MNC) theme

  

  
Investment Objective

The investment objective of the scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of multi-national companies (MNC). However, there is no assurance that the objective of the scheme will be achieved.

The investment objective of the scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of multi-national companies (MNC). However, there is no assurance that the objective of the scheme will be achieved.

Issuer/Instrument
% to Net
Assets

Equity & Equity related
Pharmaceuticals and Biotechnology 12.26
JB CHEMICALS & PHARMACEUTICALS LTD. 2.43
Sun Pharmaceuticals Industries Ltd. 2.33
Glenmark Pharmaceuticals Ltd 1.81
JUBILANT PHARMOVA LIMITED 1.61
Marksans Pharma Ltd 1.56
AMI ORGANICS LTD 1.07
ORCHID PHARMA LTD. 0.88
SAI LIFE SCIENCES LIMITED 0.57
IT - Software 9.88
Infosys Ltd. 2.83
Oracle Financial Services Software Ltd 2.74
Tech Mahindra Ltd. 2.72
Mphasis Ltd 1.59
Food Products 9.55
Britannia Industries Ltd. 5.85
NESTLE INDIA LTD. 3.70
Automobiles 9.14
Maruti Suzuki India Limited 9.14
Diversified FMCG 7.97
Hindustan Unilever Ltd. 7.97
Electrical Equipment 7.17
Siemens Ltd. 2.82
ABB India Ltd 1.79
GE VERNOVA T&D INDIA LIMITED 1.41
AZAD ENGINEERING LTD 1.15
Auto Components 5.59
Schaeffler India Ltd 1.78
Bosch Ltd. 1.22
ZF Commercial Vehicle Control Systems India Limited 1.09
SAMVARDHANA MOTHERSON INTERNATIONAL LIMITED 0.76
SONA BLW PRECISION FORGINGS LTD 0.74
Industrial Products 5.16
Timken India Ltd. 1.63
Cummins India Ltd. 1.50
Grindwell Norton Ltd. 1.29
KSB LTD 0.74
Beverages 3.51
UNITED SPIRITS LTD. 3.51
Healthcare Services 3.06
Fortis Healthcare India Ltd 1.53
ASTER DM HEALTHCARE LTD 1.53
Telecom - Services 2.62
Bharti Airtel Ltd 2.62
Retailing 2.22
SWIGGY LTD 2.22
Chemicals and Petrochemicals 2.08
Tata Chemicals Ltd 2.08
Agricultural, Commercial and Construction Vehicles 1.91
Ashok Leyland Ltd. 1.91
Personal Products 1.83
Colgate Palmolive (India ) Ltd. 1.83
Capital Markets 1.56
Nippon Life India Asset Management Ltd. 1.56
Finance 1.31
CRISIL Ltd. 1.31
Industrial Manufacturing 1.22
Tega Industries Ltd. 1.22
Aerospace and Defense 1.11
MTAR Technologies Ltd. 1.11
Leisure Services 0.19
JUNIPER HOTELS LIMITED 0.19
Equity & Equity related - Total 89.34
Triparty Repo 10.80
Net Current Assets/(Liabilities) -0.14
Grand Total 100.00



Net Asset Value (NAV)
RegularDirect
Growth Rs8.6270Rs8.6700
IDCW Rs8.6270Rs8.6700
(as on February 28, 2025)

Available Plans/Options

A) Regular Plan B) Direct Plan
Options: Growth and Income Distribution cum capital withdrawal (IDCW) (Payout and Reinvestment)


Fund Manager* Mr. Harsha Upadhyaya,
Mr. Dhananjay Tikariha &
Mr. Abhishek Bisen
BenchmarkNifty MNC Index TRI
Allotment dateOctober 28, 2024
AAUMRs2,167.87 crs
AUMRs2,026.85 crs
Folio count1,22,584

IDCW Frequency

Trustee's Discretion


Ratios
^^(P/E) 50.36
^^P/BV 6.48
Source: ^^Bloomberg

Minimum Investment Amount

Initial & Additional Investment
Rs100 and any amount thereafter
Systematic Investment Plan (SIP)
Rs 100 and any amount thereafter

Ideal Investments Horizon

• 5 years & above


Load Structure

Entry Load: Nil. (applicable for all plans)
Exit Load:
• For redemption / switch out within 90 days from the date of allotment: 0.5%
• If units are redeemed or switched out on or after 90 days from the date of allotment - Nil


Total Expense Ratio**
Regular Plan: 2.01%
Direct Plan: 0.51%

Data as on 28th February, 2025 unless otherwise specified.

Folio Count data as on 31st January 2025.

Fund


Benchmark : Nifty MNC Index TRI
This product is suitable for investors who are seeking*:
  • Long-term capital growth
  • Investment in portfolio of predominantly in equity and equity related securities of multi-national companies (MNC).

* Investors should consult their financial advisors if in doubt about whether the product is suitable for them.

The above risk-o—meter is based on the scheme portfolio as on 31st January, 2025. An addendum may be issued or updated on the website for new riskometer.

**Total Expense Ratio includes applicable B30 fee and GST.
Scheme has not completed 6 months since inception
* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'